Tissue factor expressed in pituitary adenoma cells contributes to the development of vascular events in pituitary adenomas

Cancer

Volumn 86, Issue 7, 1999, Pages 1354-1361

  Nishi, Toru ^a,b   Goto, Tomoaki ^a   Takeshima, Hideo ^a   Hamada, Kazuya ^a   Tada, Kenji ^a   Saito, Yoshiki ^a   Kochi, Masato ^a   Kuratsu, Jun Ichi ^a   Ushio, Yukitaka ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Pituitary adenoma; Pituitary apoplexy; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; BLOOD CLOTTING DISORDER; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CARCINOGENESIS; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; INFARCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE;

ADENOMA; ADULT; AGED; CYSTS; FEMALE; HEMATOMA; HUMANS; INFARCTION; LIPOPROTEINS; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS; THROMBOPLASTIN;

EID: 0033215409     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991001)86:7<1354::AID-CNCR35>3.0.CO;2-R     Document Type: Article

References (50)

1. Nemerson Y. Tissue factor and hemostasis. Blood 1988;71: 1-8.
2. Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992;11:249-66.
3. Callander NS, Varki N, Rao LV. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992;70: 1194-201.
4. Seitz R, Heidtmann HH, Maasberg M, Immel A, Egbring R, Havemann K. Activators of coagulation in cultured human lung tumor cells. Int J Cancer 1993;53:514-20.
5. Kakkar AK, De Ruvo N, Chinswangwatanakul V, Tebbutt S, Williamson RCN. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995;346: 1004-5.
6. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol 1989;134:1087-97.
7. Broze GJ Jr. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 1992;29:159-69.
8. Rapaport SI. Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood 1989;73:359-65.
9. Bajaj MS, Bajaj SP. Tissue factor pathway inhibitor: potential therapeutic applications. Thromb Haemost 1997;78:471-7.
10. Sturm U, Luther T, Albrecht S, Flossel C, Grosmann H, Muller M. Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies. Virchows Arch A Pathol Anat 1992; 421:79-86.
11. Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 1996;77:1877-83.
12. Bartha K, Brisson C, Archipoff G, de la Salle C, Lanza F, Cazenave JP, et al. Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanism. J Biol Chem 1993;268:421-9.
13. Imamura T, Iyama K, Takeya M, Kambara T, Nakamura S. Role of macrophage tissue factor in the development of the delayed hypersensitivity reaction in monkey skin. Cell Immunol 1993;152:614-22.
14. Abumiya T, Enjyoji K, Kokawa T, Kamikubo Y, Kato H. An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma. J Biochem 1995;11:178-82.
15. Hsu SM, Taine L, Fanger H. The use of antiavidin antibody and avidin-biotin peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-21.
16. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
17. Taylor CR, Shan-Rong S, Chaiwun B, Young L, Imam SA, Cote RJ. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 1994;25:263-70.
18. Kataoka H, Uchino H, Asada Y, Hatakeyama K, Nabeshima K, Sumiyoshi A, et al. Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver. Int J Cancer 1997;72:878-84.
19. Zioncheck TF, Roy S, Vehar GA. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem 1992;267:3561-4.
20. Chen Z, Sager R. Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas. Mol Med 1995;1:153-60.
21. Mizoue T, Kawamoto K, Arita K, Kurisu K, Tominaga A, Uozumi T. MIB-1 immunopositivity is associated with rapid regrowth of pituitary adenomas. Acta Neurochir 1997;139: 426-32.
22. Mohr G, Hardy J. Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol 1982;18:181.
23. Hardy J. Atlas of transsphenoidal microsurgery in pituitary tumors. New York: Igaku-Shoin, 1991.
24. Silberberg JM, Gordon S, Zucker S. Identification of tissue factor in two human pancreatic cancer cell lines. Cancer Res 1989;49:5443-7.
25. Hartzell S, Ryder K, Lanahan A, Lau LF, Nathans D. A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol 1990;9:2254-8.
26. Brox JH, Osterud B, Bjorklid E, Fenton JW II. Production and availability of thromboplastin in endothelial cells: the effect of thrombin, endotoxin and platelets. Br J Haematol 1984; 57:239-46.
27. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-23.
28. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, Mcvey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990;265:9782-7.
29. Scalpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. J Biol Chem 1989;264:20705-13.
30. Brozna JP, Carson SD. Monocyte-associated tissue factor is suppressed by phorbol myristate acetate. Blood 1988;72: 456-62.
31. Snyder PJ. Gonadotroph adenomas. In: Melmed S. The pituitary. Cambridge: Backwell Science, Inc., 1995:559-75.
32. Alexander JM, Biller BM, Bikkal H. Clinically non-functioning pituitary tumors are monoclonal in origin. J Clin Invest 1990;86:336-40.
33. Biller BM, Alexander JM, Zervas NT, Hedly-Whyte ET. Clonal origins of adrenocorticotropin-secreting pituitary tissue. J Clin Endocrinol Metab 1992;75:1303-9.
34. Arras M, Höche A, Bohle R, Eckert P, Riedel W, Schaper J. Tumor necrosis factor-α in macrophages of heart, liver, kidney, and in the pituitary gland. Cell Tissue Res 1996;285: 39-49.
35. Contrino J, Goralnick S, Qi J, Hair G, Rickles FR, Kreutzer DL. Fibrin induction of tissue factor expression in human vascular endothelial cells. Circulation 1997;96:605-13.
36. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A 1995;92:8205-9.
37. Dvorak HF, Van De Walter L, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983;43:4334-42.
38. Zhang Y, Deng Y, Wendt T, Liliensiek B, Bierhaus A, Greten J, et al. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma. J Clin Invest 1996;97:2213-24.
39. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996;2:209-15.
40. Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 1997; 275:547-50.
41. Tomiyasu U, Hirano A, Zimmerman HM. Fine structure of human pituitary adenoma. Arch Pathol 1973;95:287-92.
42. Schechter J. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 1972;67:109-26.
43. Kovacs K, Horvath E. Vascular alterations in adenomas of human pituitary glands: an electron microscopic study. Angiologica 1973;10:299-309.
44. Tani E, Ikeda K, Kudo S, Yamagata S, Makita Y, Nishiura M, et al. Freeze-fracture images of capillaries in normal and neoplastic pituitaries. Acta Neuropathol 1974;28:105-16.
45. Landolt AM. Ultrastructure of human sella tumors: correlations of clinical findings and morphology. Acta Neurochir (Wien) 1975;22(Suppl):1-167.
46. Xuereb GP, Prichard MML, Daniel PM. The arterial supply and venous drainage of the human hypophysis cerebri. Q J Exp Physiol 1954;39:199-217.
47. Tiboldi T, Nemessanyi Z, Csemay L, Kovacs K. Effect of estrogen on pituitary blood flow in rats. Endocrin Exp 1967;1:73-7.
48. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphologic study. Endocr Pathol 1995;6:115-24.
49. Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 1981;55:187-93.
50. Cardoso ER, Peterson EW. Pituitary apoplexy: a review. Neurosurgery 1984;14:363-73.